Safety and immunogenicity of PHH-1V booster against SARS-CoV-2 variants, including omicron subvariants: Results from a phase IIb open-label extension study - López MJ; Vazquez MDM; Alvarez-Mon M; Arribas JR; Arana-Arri E; Muñoz P; Navarro-Pérez J; Ramos R; Molto J; Otero-Romero S; Aurrecoechea E; Pomarol R; et al. (Human Vaccines & Immunotherapeutics, 2025)